UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016507
Receipt No. R000019170
Scientific Title A phase II study of erlotinib plus bevacizumab in patients with performance status 2 to 3 and EGFR mutation-positive advanced non-small-cell lung cancer
Date of disclosure of the study information 2015/02/10
Last modified on 2016/02/10 18:33:56

No. Disposal Last modified on Item of update
1 Insert 2015/02/10 22:52:24
2 Update 2016/02/10 18:33:56 Recruitment status


Contact us.